These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 39138395)

  • 1. Hyperimmune malarial splenomegaly in a malaria-endemic area of southwest Burkina Faso: case of Bobo-Dioulasso.
    Jacques Z; Catherine T; Yacouba S; Kongnimissom SA; Ibrahim S; Blaise SL
    BMC Infect Dis; 2024 Aug; 24(1):823. PubMed ID: 39138395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial.
    Zongo I; Dorsey G; Rouamba N; Tinto H; Dokomajilar C; Guiguemde RT; Rosenthal PJ; Ouedraogo JB
    Lancet; 2007 Feb; 369(9560):491-8. PubMed ID: 17292769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic safety of repeated treatment with pyronaridine-artesunate versus artemether-lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso.
    Compaoré YD; Zongo I; Somé AF; Barry N; Nikiéma F; Kaboré TN; Ouattara A; Kabré Z; Wermi K; Zongo M; Yerbanga RS; Sagara I; Djimdé A; Ouédraogo JB
    Malar J; 2021 Jan; 20(1):64. PubMed ID: 33514368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community-based Malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: A Multicenter (The Gambia, Burkina Faso, and Benin) Cluster-randomized Controlled Trial.
    COSMIC Consortium
    Clin Infect Dis; 2019 Feb; 68(4):586-596. PubMed ID: 29961848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso.
    Cisse M; Awandare GA; Soulama A; Tinto H; Hayette MP; Guiguemdé RT
    Malar J; 2017 Jan; 16(1):38. PubMed ID: 28114990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors for Plasmodium falciparum malaria in pregnant women attending antenatal clinic in Bobo-Dioulasso (Burkina Faso).
    Cisse M; Sangare I; Lougue G; Bamba S; Bayane D; Guiguemde RT
    BMC Infect Dis; 2014 Nov; 14():631. PubMed ID: 25408152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and factors associated with carriage of Pfmdr1 polymorphisms among pregnant women receiving intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) and artemether-lumefantrine for malaria treatment in Burkina Faso.
    Natama HM; Toussaint R; Bazié DLC; Samadoulougou S; Coulibaly-Traoré M; Tinto H; Kirakoya-Samadoulougou F
    Malar J; 2020 Nov; 19(1):399. PubMed ID: 33172485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Plasmodium falciparum infection in south-west Burkina Faso: potential impact of expanding eligibility for seasonal malaria chemoprevention.
    Yaro JB; Tiono AB; Ouedraogo A; Lambert B; Ouedraogo ZA; Diarra A; Traore A; Lankouande M; Soulama I; Sanou A; Worrall E; Agboraw E; Sagnon N; Ranson H; Churcher TS; Lindsay SW; Wilson AL
    Sci Rep; 2022 Jan; 12(1):1402. PubMed ID: 35082312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amodiaquine, sulfadoxine-pyrimethamine, and combination therapy for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Lankoande M; Ouedraogo JB; Rosenthal PJ
    Am J Trop Med Hyg; 2005 Nov; 73(5):826-32. PubMed ID: 16282288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day in vivo follow-up study.
    Coulibaly SO; Kayentao K; Taylor S; Guirou EA; Khairallah C; Guindo N; Djimde M; Bationo R; Soulama A; Dabira E; Barry B; Niangaly M; Diakite H; Konate S; Keita M; Traore B; Meshnick SR; Magnussen P; Doumbo OK; ter Kuile FO
    Malar J; 2014 Jan; 13():41. PubMed ID: 24484467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chloroquine and sulphadoxine-pyrimethamine efficacy for uncomplicated malaria treatment and haematological recovery in children in Bobo-Dioulasso, Burkina Faso during a 3-year period 1998-2000.
    Tinto H; Zoungrana EB; Coulibaly SO; Ouedraogo JB; Traoré M; Guiguemde TR; Van Marck E; D'Alessandro U
    Trop Med Int Health; 2002 Nov; 7(11):925-30. PubMed ID: 12390597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of pyrimethamine-sulfadoxine in young children with uncomplicated falciparum malaria in rural Burkina Faso.
    Müller O; Traore C; Kouyate B
    Malar J; 2004 May; 3():10. PubMed ID: 15134583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten-year surveillance of drug-resistant malaria in Burkina Faso (1982-1991).
    Guiguemde TR; Aouba A; Ouedraogo JB; Lamizana L
    Am J Trop Med Hyg; 1994 Jun; 50(6):699-704. PubMed ID: 8024062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
    Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
    Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant falciparum malaria and Hyperreactive Malarial Splenomegaly in an adolescent boy from eastern India: A tale of rare coincidences.
    Pandey S; Halder P; Patra A; Mondal M; Ghosh S; Pal D; Halder SN; Modak DC; Guha SK
    J Vector Borne Dis; 2020; 57(3):274-276. PubMed ID: 34472512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early hyperreactive malarial splenomegaly and risk factors for evolution into the full-blown syndrome: a single-centre, retrospective, longitudinal study.
    Bisoffi Z; Leoni S; Buonfrate D; Lodesani C; Eseme FE; Monteiro GB; Marocco S; Guerriero M
    Malar J; 2015 Dec; 14():487. PubMed ID: 26626013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in four malaria endemic states of India.
    Krishna S; Mishra S; Tiwari P; Vishwakarma AK; Khandai S; Shrivastava S; Verma AK; Tiwari S; Barman H; Jhariya S; Tiwari P; Tidgam AS; Varun BM; Singh S; Yerane N; Tembhurne CR; Mandavi PL; Tekam SS; Malik M; Behera KP; Jayswar H; Sonwani K; Diggikar MS; Pradhan MM; Khasotiya SS; Kumar A; Dhingra N; Bustos MDG; Christophel EM; Ringwald P; Kumari R; Shukla MM; Singh N; Das A; Bharti PK
    Malar J; 2021 May; 20(1):229. PubMed ID: 34020652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.